Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,011 | 77 | 98.9% |
| Education | $11.71 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $235.07 | 20 | $0 (2018) |
| PFIZER INC. | $98.01 | 7 | $0 (2018) |
| Novo Nordisk Inc | $88.97 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $82.23 | 6 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.42 | 6 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $61.97 | 5 | $0 (2018) |
| Allergan Inc. | $59.87 | 3 | $0 (2019) |
| AbbVie Inc. | $52.04 | 4 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $41.98 | 3 | $0 (2018) |
| Lilly USA, LLC | $38.00 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.04 | 1 | Abbott Laboratories ($19.04) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2021 | $26.32 | 2 | AbbVie Inc. ($26.32) |
| 2019 | $24.56 | 1 | Allergan Inc. ($24.56) |
| 2018 | $363.91 | 25 | Novo Nordisk Inc ($43.28) |
| 2017 | $576.91 | 48 | Janssen Pharmaceuticals, Inc ($220.16) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes Care | ||||||
| 06/10/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 11/23/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2019 | Allergan Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 09/21/2018 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Diabetes | ||||||
| 08/01/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/17/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.67 | General |
| 06/27/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: UROLOGY | ||||||
| 06/08/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Endocrinology | ||||||
| 04/27/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 04/24/2018 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Sleep | ||||||
| 04/18/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: DIABETES | ||||||
| 04/17/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/11/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/03/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Cardiology | ||||||
| 03/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: DIABETES | ||||||
| 03/06/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,411 | 2,871 | $375,162 | $173,999 |
| 2022 | 21 | 2,351 | 2,913 | $378,833 | $169,183 |
| 2021 | 24 | 2,612 | 3,301 | $411,931 | $184,333 |
| 2020 | 22 | 2,477 | 3,103 | $392,091 | $159,286 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 376 | 376 | $75,200 | $46,744 | 62.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 327 | 638 | $105,270 | $35,917 | 34.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 265 | 266 | $25,210 | $19,113 | 75.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 128 | 128 | $26,200 | $16,445 | 62.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 177 | $43,365 | $13,660 | 31.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 269 | 270 | $10,740 | $7,876 | 73.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 25 | $10,000 | $5,246 | 52.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 128 | 128 | $6,520 | $4,979 | 76.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $4,400 | $3,467 | 78.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $4,200 | $3,395 | 80.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 354 | 375 | $26,250 | $2,865 | 10.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 55 | 58 | $5,800 | $2,762 | 47.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 18 | $6,750 | $2,661 | 39.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 73 | $7,665 | $2,463 | 32.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 54 | 114 | $7,980 | $1,723 | 21.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $1,950 | $1,700 | 87.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 30 | 32 | $2,752 | $1,199 | 43.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $900.00 | $816.76 | 90.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 18 | $1,332 | $537.71 | 40.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 67 | 86 | $1,978 | $338.84 | 17.1% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 14 | 14 | $700.00 | $88.16 | 12.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 397 | 397 | $79,400 | $50,856 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 356 | 663 | $109,395 | $36,894 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 242 | $59,290 | $19,321 | 32.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 281 | 281 | $23,885 | $19,260 | 80.6% |
About Dr. Michael Hirsch, MD
Dr. Michael Hirsch, MD is a Internal Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841281623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hirsch, MD has received a total of $1,022 in payments from pharmaceutical and medical device companies, with $19.04 received in 2023. These payments were reported across 78 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,011).
As a Medicare-enrolled provider, Hirsch has provided services to 9,851 Medicare beneficiaries, totaling 12,188 services with total Medicare billing of $686,800. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hickory, NC
- Active Since 11/02/2005
- Last Updated 07/14/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841281623
Products in Payments
- INVOKANA (Drug) $180.13
- JARDIANCE (Drug) $85.05
- FARXIGA (Drug) $82.23
- XARELTO (Drug) $54.94
- Victoza (Drug) $45.64
- ELIQUIS (Drug) $44.16
- CHANTIX (Drug) $38.78
- JANUVIA (Drug) $37.56
- LINZESS (Drug) $35.31
- ENTRESTO (Drug) $31.94
- QULIPTA (Drug) $26.32
- ZENPEP (Drug) $24.56
- TOUJEO (Drug) $24.55
- Horizant (Drug) $19.14
- FREESTYLE LIBRE 3 (Device) $19.04
- Vascepa (Drug) $17.71
- SOLIQUA (Drug) $17.43
- XIFAXAN (Drug) $15.52
- VIAGRA (Drug) $15.07
- Synthroid (Drug) $14.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hickory
Dr. James Barker, M.d, M.D
Internal Medicine — Payments: $2.0M
Dr. Theodore Gray, M.d, M.D
Internal Medicine — Payments: $19,598
Jenette Swisher, Md, MD
Internal Medicine — Payments: $10,979
Dr. Graham Mcrary, Md, MD
Internal Medicine — Payments: $10,224
Mariely Castellanos Nouel, M.d, M.D
Internal Medicine — Payments: $8,664
Dr. Lawrence Carter, M.d, M.D
Internal Medicine — Payments: $7,535